Dr. Reddy's Labs Files 6-K Report

Ticker: RDY · Form: 6-K · Filed: Sep 4, 2025 · CIK: 1135951

Sentiment: neutral

Topics: reporting, foreign-private-issuer

TL;DR

Dr. Reddy's Labs filed a standard 6-K, confirming its foreign private issuer status and 20-F annual report filing.

AI Summary

Dr. Reddy's Laboratories Ltd. filed a Form 6-K on September 4, 2025, to report its status as a foreign private issuer. The company, headquartered in Hyderabad, India, is submitting this report under Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 and will file its annual reports under Form 20-F.

Why It Matters

This filing is a routine procedural document for foreign private issuers, indicating ongoing compliance with SEC reporting requirements.

Risk Assessment

Risk Level: low — This is a routine administrative filing and does not contain new financial or operational information that would typically impact risk.

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information which the issuer may be required to make public in its home country or that it may otherwise make or has made public.

What is the filing date of this Form 6-K?

This Form 6-K was filed on September 4, 2025.

What is Dr. Reddy's Laboratories Ltd.'s principal executive office address?

Dr. Reddy's Laboratories Ltd.'s principal executive office is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.

Does Dr. Reddy's Laboratories Ltd. file annual reports under Form 20-F or Form 40-F?

Dr. Reddy's Laboratories Ltd. indicates it files annual reports under cover of Form 20-F.

What is the Commission File Number for Dr. Reddy's Laboratories Ltd.?

The Commission File Number for Dr. Reddy's Laboratories Ltd. is 1-15182.

Filing Stats: 400 words · 2 min read · ~1 pages · Grade level 16.4 · Accepted 2025-09-04 13:25:40

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY'S LABORATORIES LIMITED (Registrant) Date: September 4, 2025 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing